Evidence map›Paper›PMID 40353928›Full record

ArticleWorld journal of urology2025

A novel predictive method for URS and laser lithotripsy using machine learning and explainable AI: results from the FLEXOR international database.

Carlotta Nedbal, Vineet Gauhar, Sairam Adithya, Pietro Tramanzoli, Nithesh Naik, Shilpa Gite, Het Sevalia, Daniele Castellani, Frédéric Panthier, Jeremy Y C Teoh and 8 more

Abstract readMulticenter Study
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The future of endourology is now.World journal of urology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Carlotta NedbalASST Fatebenefratelli Sacco, Urology, Milan, Italy. carlottanedbal@gmail.com.ORCID http://orcid.org/0000-0003-2031-347X
Vineet GauharEndourology Section, European Association of Urology, Arnhem, The Netherlands.
Sairam AdithyaSymbiosis Institute of Technology, Engineering, Pune, India.
Pietro TramanzoliAzienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Polytechnic University Le Marche, Ancona, Italy.
Nithesh NaikManipal Academy of Higher Education, Engineering, Manipal, India.
Shilpa GiteSymbiosis Institute of Technology, Engineering, Pune, India.
Het SevaliaSymbiosis Institute of Technology, Engineering, Pune, India.
Daniele CastellaniEndourology Section, European Association of Urology, Arnhem, The Netherlands.
Frédéric PanthierSorbonne University GRC Urolithiasis no. 20, Tenon Hospital, Paris, France.
Jeremy Y C TeohThe Chinese University of Hong Kong, Urology, Hong Kong, China.
Ben H ChewUniversity of British Columbia, Urology, Vancouver, Canada.
Khi Yung FongYong Loo Lin School of Medicine, National University of Singapore, Urology, Singapore, Singapore.
Mohammed BoulmaniBoston Scientific - Urology and Pelvic Health, Paris, France.
Nariman GadzhievPavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.
Abhishek Gajendra SinghMuljibhai Patel Urological Hospital, Nadiad, Gujarat, India.
Thomas R W HerrmannKantonspital Frauenfeld, Spital Thurgau AG, Frauenfeld, Switzerland.
Olivier TraxerSorbonne University GRC Urolithiasis no. 20, Tenon Hospital, Paris, France.
Bhaskar K SomaniUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe developed Machine learning (ML) algorithms to predict ureteroscopy (URS) outcomes, offering insights into diagnosis and treatment planning, personalised care and improved clinical decision-making.

methodsFLEXOR is a large international multicentric database including 6669 patients treated with URS for urolithiasis from 2015 to 2023. Preoperative and postoperative(PO) correlations were investigated through 15 ML-trained algorithms. Outcomes included stone free status (SFS, at 3-month imaging follow up), intraoperative (PCS bleeding, ureteric/PCS injury, need for postoperative drainage) and PO complications (fever, sepsis, need for reintervention). ML was applied for the prediction, correlation and logistic regression analysis. Explainable AI emphasizes key features and their contributions to the output.

resultsExtra Tree Classifier achieved the best accuracy (81%) in predicting SFS. PCS bleed was negatively linked with 'positive urine culture'(-0.08), 'tamsulosin'(-0.08), 'stone location'(-0.10), 'fibre optic scope'(-0.19), 'Moses Fibre'(-0.09), and 'TFL'(-0.09), and positively with 'elevated creatine'(0.25), 'fever'(0.11), and 'stone diameter'(0.21). 'PCS injury' and 'ureteric injury' both showed moderate correlation with 'elevated creatinine'(0.11), 'fever'(0.10), and 'lower pole stone'(0.09). 'Tamsulosin'(0.23) use, presence of 'multiple'(0.25) or 'lower pole'(0.25) stones, 'reusable scope'(0.17) and 'Moses Fibre'(0.2546) increased the risk for PO stent, while 'digital scope'(-0.13) or 'TFL'(-0.29) reduced it. 'Preoperative fever'(0.10), 'positive urine culture'(0.16), and 'stone diameter'(0.10) may play a role in 'PO fever' and 'sepsis'. SFS was mainly influenced by 'age'(0.12), 'preoperative fever'(0.09), 'multiple stones'(0.15), 'stone diameter'(0.17), 'Moses Fibre"(0.15) and 'TFL'(-0.28).

conclusionML is valuable tool for accurately predicting outcomes by analysing pre-existing datasets. Our model demonstrated strong performance in outcomes and risks prediction, laying the groundwork for development of accessible predictive models.

Indexed as

Lithotripsy, LaserMachine LearningUreteral CalculiUreteroscopyUrolithiasisAdultDatabases, FactualFemaleHumansMaleMiddle AgedPredictive Value of TestsArtificial intelligenceExplainable AIMachine learningOutcomes predictionUreteroscopyUrolithiasis

Identifiers

PMID40353928
PMCPMC12069140

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.